ALPHAHELIX MOL.DIAGN. SK1 (4MB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a cash flow conversion efficiency ratio of 1.857x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.18 Million ≈ $1.38 Million USD) by net assets (€637.00K ≈ $744.72K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ALPHAHELIX MOL.DIAGN. SK1 - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how ALPHAHELIX MOL.DIAGN. SK1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4MB total debt and obligations for a breakdown of total debt and financial obligations.
ALPHAHELIX MOL.DIAGN. SK1 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ALPHAHELIX MOL.DIAGN. SK1 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sobr Safe Inc
NASDAQ:SOBR
|
-0.338x |
|
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
|
-0.009x |
|
Eurotex Industries and Exports Limited
NSE:EUROTEXIND
|
0.047x |
|
Pathfinder Ventures Inc
V:RV
|
0.233x |
|
Digjam Limited
NSE:DIGJAMLTD
|
-0.688x |
|
Global Energy Metals Corp
V:GEMC
|
-0.011x |
|
Sienna Resources Inc
V:SIE
|
-0.071x |
|
Gossan Resources Ltd
V:GSS
|
-0.341x |
Annual Cash Flow Conversion Efficiency for ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)
The table below shows the annual cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see ALPHAHELIX MOL.DIAGN. SK1 stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €637.00K ≈ $744.72K |
€820.00K ≈ $958.67K |
1.287x | +219.69% |
| 2024-12-31 | €4.18 Million ≈ $4.88 Million |
€-4.49 Million ≈ $-5.25 Million |
-1.076x | -105.67% |
| 2023-12-31 | €10.41 Million ≈ $12.18 Million |
€-5.45 Million ≈ $-6.37 Million |
-0.523x | -462.81% |
| 2022-12-31 | €19.89 Million ≈ $23.25 Million |
€2.87 Million ≈ $3.35 Million |
0.144x | -- |
About ALPHAHELIX MOL.DIAGN. SK1
Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to … Read more